ObesityZealand pays Chinese OTR US$30m upfront to expand obesity pipelineDanish Zealand Pharma A/S partners with Chinese start-up OTR Therapeutics Co. Ltd to expand oral obesity pipeline in US$30m upfront deal. more ➔
Momoneymoproblemz - wikimediaObesityLilly‘s retatrutide delivers record weight lossLilly’s triple weight loss combination therapy retatrutide has shown 28.7% weight loss in Phase 3, but higher discontinuations vs. tirzepatide and semaglutide. more ➔
San Antonio Breast Cancer SymposiumBreast CancerPfizer presents data for Tukysa in HER2-positive breast cancerPfizer’s Tukysa improves progression-free survival in first-line HER2-positive breast cancer, especially in HR-negative patients, with manageable safety. Data were shown at the 2025 San Antonio Breast … more ➔
PubChemBreast cancerRoche presents details on breast cancer pill giredestrantRoche has unveiled detailed data for its oral selective estrogen receptor degrader (SERD), giredestrant, at the 2025 San Antonio Breast Cancer Symposium. more ➔
adobe stock photos - deemerwhaFinancingDisco Pharmaceuticals GmbH expands seed financingCologne-based Disco Pharmaceuticals GmbH has closed its seed financing at €36m. The company will use the proceeds to advance its surfaceome-mapping platform, developing bispecific ADCs and T-Cell Engagers … more ➔
Tetraneuron SL - Álvaro GarcíaFinancingTetraneuron secures funding for Alzheimer’s gene therapy trialSpanish Tetraneuron secures financing to advance its E2F4DN-based Alzheimer’s gene therapy, restoring neuronal homeostasis and halting disease progression in Europe. more ➔
Cellular Origins LtdFinancingCellular Origins secures major CGT funding breakthroughUK-bad Cellular Origins Ltd raised $40m to scale global CGT manufacturing with robotic automation, boosting access to cell therapies and enabling commercial growth. more ➔
SLASSLASSLAS announces finalists for the 2026 Ignite AwardThe Society for Laboratory Automation and Screening (SLAS) has unveiled the Ignite Award finalists: eight pioneering lab automation and drug discovery start-ups competing for $5,000 at SLAS 2026 in Boston, … more ➔
Melt & Marble ABFinancingMelt&Marble secures €7.3m Series A to scale designer fatsSwedish Melt&Marble AB has raised €7.3m to scale precision-fermented designer fats for sustainable, high-performance food and personal care ingredients. more ➔
© peterschreiber. media - stock.adoImmunoncologyPoolbeg takes centre stage in CRS researchCancer immunotherapies can save lives, yet their side effect — cytokine release syndrome (CRS) — remains a barrier for wider use, even though IL 6 receptor antagonists can treat it. Now the UK company … more ➔
Momoneymoproblemz - wikimedia
San Antonio Breast Cancer Symposium
PubChem
adobe stock photos - deemerwha
Tetraneuron SL - Álvaro García
Cellular Origins Ltd
SLAS
Melt & Marble AB
© peterschreiber. media - stock.ado